Cancel
Joanne Zhongyan Zhang M.D., PhD
Director of Micro and Biology
@
Clene Nanomedicine
tfrwhu@466i2.wwt
Sign up to see email
Known information
- Spent over six years working as an attending physician and chief physician at Tianjin First Central Hospital
- Was a postdoctoral fellow in Cell Biology at Johns Hopkins University
- Worked as a research associate in the Cardiology Department at Duke University
- Was awarded Special Fellow status by the Japan Society for the Promotion of Science while working at Osaka University
- Was awarded a medical degree from Tianjin Medical University
- Received a PhD from the Cardiology Division of Internal Medicine and Molecular Science at Osaka University
- Helped design and personally executed the initial and validated Cuprizone Studies of Clene’s asset, CNM Au8
- Designed and directed the ALS pilot study proving that Au8 improved motor coordination in the congenic ALS SOD1 G93A mouse model
About Clene Nanomedicine
Clene Nanomedicine is a biopharmaceutical company focused on developing nanotherapeutics for neurodegenerative diseases, with its lead candidate, CNM-Au8, targeting ALS, MS, and Parkinson's Disease.
Report inaccurate information
